Assess Part D’s Impact, Understand Fraud & Abuse Concerns, Respond to Changes in the Beneficiary Landscape and Maximize the Value of Your PAP
“On a daily basis over 36 million Americans wake up and rely on Patient Assistance Programs. We should all pat ourselves on the back for our efforts in serving these Americans.”
–Speaker at the 2005 Patient Assistance Programs Conference, Forest Harper, Vice President, Pfizer
Current trends suggest PAPs will continue to grow at an unprecedented pace, creating a need for new eligibility guidelines and systems designed to organize and streamline the volume of patient data being received. With the upcoming Part D implementation in January of 2006 and the need to balance profitability against public responsibility and perception, PAPs are a pressing issue within the industry.
For the past six years, CBI has been pleased to provide the must-attend forum for executives engaged in pharmaceutical patient assistance programs to convene and to learn. This conference provides pharmaceutical companies with strategies for designing and maintaining their patient assistance programs. It creates a forum in which companies learn how to structure a program to meet corporate objectives, respond to changes in patient privacy and Medicare legislation and handle the growing volume of applicants/participants.
“The information was wonderful! Very informative, clear and just great! Thanks for the HUGE update. See you next year!”
– Tammy Billings, Supervisor of PAP, Cenla Medication Access Program
Women’s Health & Wellness – Communications & Partnership Opportunities